Prevention of colorectal cancer by colonoscopic surveillance in families with hereditary colorectal cancer

Scandinavian Journal of Gastroenterology

Volumn 42, Issue 5, 2007, Pages 611-617

  Stormorken, Astrid T ^a   Clark, Neal ^a   Grindedal, Eli ^a   Mæhle, Lovise ^a   Møller, Pål ^a  

^a OSLO UNIVERSITY HOSPITAL   (Norway)

Author keywords

Adenomas; Colonoscopy; Colorectal cancer; HNPCC; Incidence; MMR mutations; Polyps; Prevention; Prospective; Surveillance

Indexed keywords

ADULT; AGED; ARTICLE; CANCER INFILTRATION; CANCER PREVENTION; CANCER RISK; CANCER SCREENING; COLON ADENOMA; COLON POLYP; COLONOSCOPY; COLORECTAL CANCER; COURSE EVALUATION; DISEASE COURSE; EPITHELIUM HYPERPLASIA; FAMILIAL CANCER; FAMILY HISTORY; FEMALE; FOLLOW UP; GASTROINTESTINAL DYSPLASIA; GENE MUTATION; HUMAN; MALE; MISMATCH REPAIR; OBSERVATIONAL STUDY; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK ASSESSMENT; SCORING SYSTEM;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ADULT; AGED; COLONOSCOPY; COLORECTAL NEOPLASMS; COLORECTAL NEOPLASMS, HEREDITARY NONPOLYPOSIS; DISEASE PROGRESSION; DNA MISMATCH REPAIR; DNA MUTATIONAL ANALYSIS; DNA, NEOPLASM; DNA-BINDING PROTEINS; FAMILY; FEMALE; FOLLOW-UP STUDIES; GENETIC PREDISPOSITION TO DISEASE; HUMANS; INCIDENCE; MALE; MIDDLE AGED; MUTATION; MUTS HOMOLOG 2 PROTEIN; NORWAY; NUCLEAR PROTEINS; POPULATION SURVEILLANCE; PROSPECTIVE STUDIES; TIME FACTORS;

EID: 34247326511     PISSN: 00365521     EISSN: 15027708     Source Type: Journal    
DOI: 10.1080/00365520601010230     Document Type: Article

References (35)

1. Cancer Registry of Norway. www.kreftregisteret.no
2. Houlston RS, Collins A, Slack J, Morton NE. Dominant genes for colorectal cancer are not rare. Ann Hum Genet 1992;56:99-103.
3. Watson P, Lynch HT. The tumour spectrum in HNPCC. Anticancer Res 1994;14(4B):1635-9.
4. Lynch HT, Smyrk T, Jass JR. Hereditary nonpolyposis colorectal cancer and colonic adenomas: aggressive adenomas? Semin Surg Oncol 1995;11:406-10.
5. Aarnio M, Sankila R, Pukkala E, Salovaara R, Aaltonen LA, de la Chapelle A, et al. Cancer risk in mutation carriers of DNA-mismatch-repair genes. Int J Cancer 1999;81:214-8.
6. Vogelstein B, Fearon ER, Hamilton SR, Kern SE, Preisinger AC, Leppert M, et al. Genetic alterations during colorectal-tumor development. N Engl J Med 1988;319:525-32.
7. Kinzler KW, Vogelstein B. Lessons from hereditary colorectal cancer. Cell 1996;87:159-70.
8. Järvinen HJ, Aarnio M, Mustonen H, Aktan-Collan K, Aaltonen LA, Peltomäki P, et al. Controlled 15-year trial on screening for colorectal cancer in families with hereditary nonpolyoposis colorectal cancer. Gastroenterology 2000;118:829-34.
9. Winawer SJ, Zauber AG, Ho MN, O'Brien MJ, Gotlieb LS, Sternberg SS, et al. Prevention of colorectal cancer by colonoscopic polypectomy. N Engl J Med 1993;329:1977-81.
10. Thiis-Evensen E, Hoff GS, Sauar J, Langmark F, Majak BM, Vatn MH. Population-based surveillance by colonoscopy: effect on the incidence of colorectal cancer. Scand J Gastroenterol 1999;34:414-20.
11. Rex DK, Smith JJ, Ulbright TM, Lehman GA. Distal colonic hyperplastic polyps do not predict proximal adenomas in asymptomatic average-risk subjects. Gastroenterology 1992;102:317-9.
12. Rijcken FEM, van der Sluis T, Hollema H, Kleibeuker JH. Hyperplastic polyps in hereditary non-polyposis colorectal cancer. Am J Gastronterol 2003;98:2306-11.
13. Leach FS, Nicolaides NC, Papadopoulos N, Liu B, Jen J, Parsons R, et al. Mutations of a mutS homolog in hereditary nonpolyposis colorectal cancer. Cell 1993;75:1215-25.
14. Bronner CE, Baker SM, Morrison PT, Warren G, Smith LG, Lescoe MK, et al. Mutation in the DNA mismatch repair gene homologue MLH1 is associated with hereditary non-polyposis colon cancer. Nature 1994;368(6468):258-61.
15. Nicolaides NC, Papadopoulos N, Liu B, Wei YF, Carter KC, Ruben SM, et al. Mutation of two PMS homologues in hereditary nonpolyposis colon cancer. Nature 1994;371:75-80.
16. Papadopoulos N, Nicolaides NC, Wei YF, Ruben S, Carter KC, Rosen CA, et al. Mutation of a mutL homolog in hereditary colon cancer. Science 1994;263:1625-9.
17. Dunlop MG, Farrington SM, Carothers AD, Wyllie AH, Sharp L, Burn J, et al. Cancer risk associated with germline DNA mismatch repair gene mutations. Hum Mol Genet 1997;6:105-10.
18. Vasen HF, Nagengast FM, Khan PM. Interval cancers in hereditary non-polyposis colorectal cancer (Lynch syndrome). Lancet 1995;345:1183-4.
19. Jass JR, Stewart SM. Evolution of hereditary non-polyposis colorectal cancer. Gut 1992;33:783-6.
20. Lynch HT, de la Chapelle A. Genetic susceptibility to nonpolyposis colorectal cancer. J Med Genet 1999;36:801-18.
21. Stryker SJ, Wolff BG, Culp CE, Libbe SD, Ilstrup DM, MacCarty RL. Natural history of untreated colonic polyps. Gastroenterology 1987;93:1009-13.
22. Bonithon-Kopp C, Benhamiche AM. Are there several colorectal cancers? Epidemiological data. Eur J Cancer Prev 1999;8:3-12.
23. Eide TJ, Stalsberg H. Polyps of the large intestine in Northern Norway. Cancer 1978;42:2839-48.
24. Thiis-Evensen E, Hoff GS, Sauar J, Majak BM, Vatn MH. Flexible sigmoidoscopy or colonoscopy as a screening modality for colorectal adenomas in older age groups? Findings in a cohort of the normal population aged 63-72 years. Gut 1999;45:834-9.
25. Vatn MH, Stalsberg H. The prevalence of polyps of the large intestine in Oslo: an autopsy study. Cancer 1982;49:819-25.
26. Møller P. Genetic cancer: a challenge and a possible strategy. J Cancer Care 1993;2:94-9.
27. Vasen HF, Watson P, Mecklin J-P, Lynch HT. ICGHNPCC. New clinical criteria for hereditary non-polyposis colorectal cancer (HNPCC, Lynch syndrome) proposed by the international collaborative group on HNPCC. Gastroenterology 1999;116:1453-6.
28. Norwegian Gastrointestinal Cancer Group (NGICG). Norwegian. http://ngicg.no
29. Stormorken AT, Muller W, Lemkemeyer B, Apold J, Wijnen JT, Fodde R, et al. Prediction of the outcome of genetic testing in HNPCC kindreds using the revised Amsterdam criteria and immunohistochemistry. Fam Cancer 2001;1:169-73.
30. Stormorken AT, Bowitz-Lothe IM, Noren T, Kure E, Aase S, Wijnen J, et al. Immunohistochemistry identifies carriers of mismatch repair gene defects causing hereditary nonpolyposis colorectal cancer. J Clin Oncol 2005;23:4705-12.
31. ICG-HNPCC. (http://www.insight-group.org/)
32. Vasen HF, Wijnen JT, Menko FH, Kleibeuker JH, Taal BG, Griffioen G, et al. Cancer risk in families with hereditary nonpolyposis colorectal cancer diagnosed by mutation analysis. Gastroenterology 1996;110:1020-7.
33. Vasen HF, Stormorken A, Menko F, Nagengast FM, Kleibeuker JH, Griffioen G, et al. MSH2 mutation carriers are at higher risk of cancer than MLH1 mutation carriers: a study of hereditary nonpolyposis colorectal cancer families. J Clin Oncol 2001;19:4074-80.
34. Dove-Edwin I, Sasieni P, Adama J, Thoma HJW. Prevention of colorectal cancer by colonoscopic surveillance in individuals with a family history of coloretal cancer: 16 year, prospective, follow-up study. Br Med J 2005;331:1047-53.
35. Dove-Edwin I, De Jong AE, Adams J, Mesher D, Lipton L, Sasieni P, et al. Prospective results of surveillance colonoscopy in dominant familial colorectal cancer with and without Lynch syndrome. Gastroenterology 2006;130:1995-2000.